These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30844538)

  • 41. Determination of antibody concentration as the main parameter in a dengue virus antibody-dependent enhancement assay using FcγR-expressing BHK cells.
    Moi ML; Takasaki T; Saijo M; Kurane I
    Arch Virol; 2014 Jan; 159(1):103-16. PubMed ID: 23900750
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antibody-Dependent Dengue Virus Entry Modulates Cell Intrinsic Responses for Enhanced Infection.
    Chan CYY; Low JZH; Gan ES; Ong EZ; Zhang SL; Tan HC; Chai X; Ghosh S; Ooi EE; Chan KR
    mSphere; 2019 Sep; 4(5):. PubMed ID: 31533998
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of an antibody-dependent enhancement assay for dengue virus using stable BHK-21 cell lines expressing Fc gammaRIIA.
    Moi ML; Lim CK; Kotaki A; Takasaki T; Kurane I
    J Virol Methods; 2010 Feb; 163(2):205-9. PubMed ID: 19781573
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Zika Virus-Induced Antibody Response Enhances Dengue Virus Serotype 2 Replication In Vitro.
    Kawiecki AB; Christofferson RC
    J Infect Dis; 2016 Nov; 214(9):1357-1360. PubMed ID: 27521359
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to Dengue Virus Serotype 4 Infection and Vaccination.
    Nivarthi UK; Kose N; Sapparapu G; Widman D; Gallichotte E; Pfaff JM; Doranz BJ; Weiskopf D; Sette A; Durbin AP; Whitehead SS; Baric R; Crowe JE; de Silva AM
    J Virol; 2017 Mar; 91(5):. PubMed ID: 28031369
    [TBL] [Abstract][Full Text] [Related]  

  • 46. prM-reactive antibodies reveal a role for partially mature virions in dengue virus pathogenesis.
    Dowd KA; Sirohi D; Speer SD; VanBlargan LA; Chen RE; Mukherjee S; Whitener BM; Govero J; Aleshnick M; Larman B; Sukupolvi-Petty S; Sevvana M; Miller AS; Klose T; Zheng A; Koenig S; Kielian M; Kuhn RJ; Diamond MS; Pierson TC
    Proc Natl Acad Sci U S A; 2023 Jan; 120(3):e2218899120. PubMed ID: 36638211
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of a potent and highly unusual minimally enhancing antibody directed against dengue virus.
    Renner M; Flanagan A; Dejnirattisai W; Puttikhunt C; Kasinrerk W; Supasa P; Wongwiwat W; Chawansuntati K; Duangchinda T; Cowper A; Midgley CM; Malasit P; Huiskonen JT; Mongkolsapaya J; Screaton GR; Grimes JM
    Nat Immunol; 2018 Nov; 19(11):1248-1256. PubMed ID: 30323338
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dengue virus infection-enhancing activity of undiluted sera obtained from patients with secondary dengue virus infection.
    Moi ML; Takasaki T; Saijo M; Kurane I
    Trans R Soc Trop Med Hyg; 2013 Jan; 107(1):51-8. PubMed ID: 23296697
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation by flow cytometry of antibody-dependent enhancement (ADE) of dengue infection by sera from Thai children immunized with a live-attenuated tetravalent dengue vaccine.
    Guy B; Chanthavanich P; Gimenez S; Sirivichayakul C; Sabchareon A; Begue S; Yoksan S; Luxemburger C; Lang J
    Vaccine; 2004 Sep; 22(27-28):3563-74. PubMed ID: 15315835
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of dendritic cells in antibody-dependent enhancement of dengue virus infection.
    Boonnak K; Slike BM; Burgess TH; Mason RM; Wu SJ; Sun P; Porter K; Rudiman IF; Yuwono D; Puthavathana P; Marovich MA
    J Virol; 2008 Apr; 82(8):3939-51. PubMed ID: 18272578
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Can we find a possible structural explanation for antibody-dependent enhancement of dengue virus infection resulting in hemorrhagic fever?
    Mikita CP; Padlan EA
    Med Hypotheses; 2016 Mar; 88():49-52. PubMed ID: 26880637
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Generation of Monoclonal Antibodies against Dengue Virus Type 4 and Identification of Enhancing Epitopes on Envelope Protein.
    Tang CT; Liao MY; Chiu CY; Shen WF; Chiu CY; Cheng PC; Chang GJ; Wu HC
    PLoS One; 2015; 10(8):e0136328. PubMed ID: 26309127
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice.
    Watanabe S; Chan KW; Wang J; Rivino L; Lok SM; Vasudevan SG
    J Virol; 2015 Jun; 89(11):5847-61. PubMed ID: 25787279
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of single-round infectious, chimeric dengue type 1 virus as an antigen for dengue functional antibody assays.
    Yamanaka A; Suzuki R; Konishi E
    Vaccine; 2014 Jul; 32(34):4289-95. PubMed ID: 24950360
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neutralization of antibody-enhanced dengue infection by VIS513, a pan serotype reactive monoclonal antibody targeting domain III of the dengue E protein.
    Budigi Y; Ong EZ; Robinson LN; Ong LC; Rowley KJ; Winnett A; Tan HC; Hobbie S; Shriver Z; Babcock GJ; Alonso S; Ooi EE
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006209. PubMed ID: 29425203
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serotype-specific anti-Dengue virus NS1 mouse antibodies cross-react with prM and are potentially involved in virus production.
    Masrinoul P; Omokoko MD; Pambudi S; Ikuta K; Kurosu T
    Viral Immunol; 2013 Aug; 26(4):250-8. PubMed ID: 23941673
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of two anti-dengue human monoclonal antibodies prepared from PBMCs of patients with dengue illness in Thailand.
    Li ZY; Yamashita A; Kawashita N; Sasaki T; Pan Y; Ono KI; Ikuta K; Li YG
    Acta Virol; 2016 Jun; 60(2):166-73. PubMed ID: 27265466
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cell type specificity and host genetic polymorphisms influence antibody-dependent enhancement of dengue virus infection.
    Boonnak K; Dambach KM; Donofrio GC; Tassaneetrithep B; Marovich MA
    J Virol; 2011 Feb; 85(4):1671-83. PubMed ID: 21123382
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development and characterization of mouse monoclonal antibodies against monomeric dengue virus non-structural glycoprotein 1 (NS1).
    Gelanew T; Poole-Smith BK; Hunsperger E
    J Virol Methods; 2015 Sep; 222():214-23. PubMed ID: 26070890
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Interplay of Dengue Virus Morphological Diversity and Human Antibodies.
    Lok SM
    Trends Microbiol; 2016 Apr; 24(4):284-293. PubMed ID: 26747581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.